A medical device developer specializing in treatments for metabolic disorders, company is known for developing a cryolipolysis device to target mesenteric fat, which is associated with metabolic disorders. B2M Medical, Inc. has received a total of $825,000 in funding -- to include SBIR award from HHS - to develop the firm's innovative solutions for respiratory and medical protection.